AWARDDEFINITIVE CONTRACTOther than small business
Definitive contract 75N93023C00041THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
Overview
Award facts
- Net obligations
- $2.50M
- $2,501,040of $2.50M potential value
- Outlays (paid to date)
- $1.61M
- $1.61M paid of $2.50M obligated$1,609,407
- Period of performance
- Sep 30, 2023 to Mar 7, 2025
- Ended
- Modifications
- 3
- Latest action Mar 7, 2025
- Contract type
- Definitive contract
- PIID 75N93023C00041
Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.
Description of requirement
A GLYCOLIPID ADJUVANT 7DW8-5 FOR MALARIA VACCINES
Dates and value
- Award date
- Signed on Aug 29, 2023
- Potential end of performance
- Sep 28, 2025
- Current value
- $2,501,040Base and exercised options
- Potential value (if all options are exercised)
- $2,501,040
Obligations by fiscal year of action
- FY2024: $1,089,350
- FY2023: $1,411,690
Total across 2 fiscal years: $2,501,040
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Mar 7, 2025. View on USAspending · Recipient on SAM.gov
Recipient
LocationNEW YORK, NY
UEIQHF5ZZ114M72
CAGE code3FHD3
Business sizeOther than small businessSize at award, per the contracting officer
Business types and certifications
Nonprofit organizationEducational institution
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NIAID
- Funded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NIAID
- Funded from
- National institute of allergy and infectious diseases (0885)Program activities075-0885Federal accounts (agency financial reports)
Place of performance
- Place of performance
- New York, New York 10032-3702
- Congressional district (place of performance)
- NY-13As reported at the time of the action
Classification and competition
Classification
- Product or service (PSC)
- AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH (research and development)
Competition
- Extent competed
- Full and open competitionA
- Solicitation procedures
- Negotiated proposal/quoteNP
- Set-aside
- No set-aside used
- Contract pricing
- Firm fixed priceJ
- Offers received
- 24
Solicitation and notices
- Solicitation ID
- 75N93022R00009(as reported)
- Solicitation date
- Apr 13, 2022
Contract details
- Subcontracting plan
- Individual subcontract planF
- Cost Accounting Standards clause
- Not applicable exempt from CASX
- Certified cost or pricing data
- Yes
- Commercial procedures
- Commercial products/services procedures not usedD
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
- Multi-year contract
- Yes
- Performance-based service acquisition
- Yes - service where PBA is used.Y
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Aug 29, 2023Base obligation at award: $1,411,690
- Latest action
- Mar 7, 2025 — Terminated for convenienceModification P00003
- Latest substantive action
- Mar 7, 2025 — Terminated for convenienceModification P00003
- Actions by type
- Base award1
- Terminated for convenience1
- Option exercised1
- Other administrative action1
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Synopsized publicly (SAM.gov / FedBizOpps)
- Yes
- Simplified procedures for commercial items
- No
Pricing and financing
- Paid by purchase card
- No
Socio-economic and policy
- Inherently governmental functions
- Other functionsOT
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Not a manufactured end productC
Structure
- Award or IDV
- Award
- Award type
- Definitive contractD
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7529
- Contracting office code
- 75N930
- Transactions recorded under this award key
- 4
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7529
- Funding office code
- 75N930
- Treasury accounts
- 075-2023/2023-0885-000
- 075-2024/2024-0885-000
- Object classes
- 25.5: Research and development contracts
- Disaster or emergency funding (DEFC)
- Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression